Familial Nasopharyngeal Carcinoma 6

136 J-C. LinWang CC (1991) Improved local control of nasopharyngealcarcinoma after intracavitary brachytherapy boost. Am JClin Oncol 14:5–8Wang WY, Chien YC, Jan JS, Chueh CM, Lin JC (2002) Consistentsequence variation of Epstein–Barr virus nuclear antigen 1in primary tumor and peripheral blood cells of patients withnasopharyngeal carcinoma. Clin Cancer Res 8:2586–2590Wang XS, Hu CS, Ying HM, Zhou ZR, Ding JH, Feng Y (2009)Patterns of retropharyngeal node metastasis in nasopharyngealcarcinoma. Int J Radiat Oncol Biol Phys 73:194–201Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET,Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V,Chua EJ, Machin D (2005) Randomized trial of radiotherapyversus concurrent chemoradiotherapy followed byadjuvant chemotherapy in patients with American JointCommittee on Cancer/International Union Against Cancerstage III and IV nasopharyngeal cancer of the endemicvariety. J Clin Oncol 23:6730–6738Willner J, Baier K, Pfreundner L, Flentje M (1999) Tumor volumeand local control in primary radiotherapy of nasopharyngealcarcinoma. Acta Oncol 38:1025–1030Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, ZelefskyMJ (2006) Intensity-modulated radiation therapy (IMRT)for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64:57–62Xiao GL, Gao L, Xu GZ (2002) Prognostic influence of parapharyngealspace involvement in nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys 52:957–963Yan JH, Xu GZ, Hu YH, Li SY, Lie YZ, Qin DX, Wu XL, Gu XZ (1990)Management of local residual primary lesion of nasopharyngealcarcinoma: II. Results of prospective randomized trial onbooster dose. Int J Radiat Oncol Biol Phys 18:295–298Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY (2005) Treatmentoutcomes and late complications of 849 patients withnasopharyngeal carcinoma treated with radiotherapy alone.Int J Radiat Oncol Biol Phys 62:672–679Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL (2005)Early restaging whole-body 18 F-FDG PET during inductionchemotherapy predicts clinical outcome in patients withlocoregionally advanced nasopharyngeal carcinoma. EurJ Nucl Med Mol Imaging 32:1152–1159Yen TC, Lin CY, Wang HM, Huang SF, Liao CT, Kang CJ, Ng SH,Chan SC, Fan KH, Chen IH, Lin WJ, Cheng AJ, Chang JT(2006) 18F-FDG-PET for evaluation of the response to concurrentchemoradiation therapy with intensity-modulatedradiation technique for stage T4 nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys 65:1307–1314Yeung WM, Zong YS, Chiu CT, Chan KH, Sham JS, Choy DT, NgMH (1993) Epstein–Barr virus carriage by nasopharyngealcarcinoma in situ. Int J Cancer 53:746–750Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP, Xu GZ(2006) Nasopharyngeal carcinoma treated by radical radiotherapyalone: Ten-year experience of a single institution.Int J Radiat Oncol Biol Phys 65:161–168Yip TT, Ngan RK, Lau WH, Poon YF, Joab I, Cochet C, Cheng AK(1994) A possible prognostic role of immunoglobulin-Gantibody against recombinant Epstein–Barr virus BZLF-1transactivator protein ZEBRA in patients with nasopharyngealcarcinoma. Cancer 74:2414–2424Yip TT, Lau WH, Chan JK, Ngan RK, Poon YF, Lung CW, Lo TY,Ho JH (1998) Prognostic significance of DNA flow cytometricanalysis in patients with nasopharyngeal carcinoma.Cancer 83:2284–2292Zeng Y, Zhong JM, Li LY, Wang PZ, Tang H, Ma YR, Zhu JS, PanWJ, Liu YX, Wei ZN, et al (1983) Follow-up studies onEpstein–Barr virus IgA/VCA antibody-positive persons inZangwu County, China. Intervirology 20:190–194Zhang EP, Lian PG, Cai KL, Chen YF, Cai MD, Zheng XF,Guang XX (1989) Radiation therapy of nasopharyngealcarcinoma: prognostic factors based on a 10-year followupof 1302 patients. Int J Radiat Oncol Biol Phys 16:301–305Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, Wu SX(2005) Phase III study comparing standard radiotherapywith or without weekly oxaliplatin in treatment of locoregionallyadvanced nasopharyngeal carcinoma: preliminaryresults. J Clin Oncol 23:8461–8468Zhou JY, Chong VF, Khoo JB, Chan KL, Huang J (2007) Therelationship between nasopharyngeal carcinoma tumorvolume and TNM T-classification: a quantitative analysis.Eur Arch Otorhinolaryngol 264:169–174